Kyverna Therapeutics, Inc. · NASDAQ:KYTX
Bain Capital Life Sciences Opportunities III, LP's stake in Kyverna Therapeutics, Inc. fell to 4.75% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Bain Capital Life Sciences Opportunities III, LP's stake in Kyverna Therapeutics, Inc. fell to 4.75%, 2,885,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.75%
- Shares
- 2,885,000
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bain Capital Life Sciences Opportunities III, LP | 4.75% | 2,885,000 |
Source
Related
- Kyverna Therapeutics, Inc.
- Bain Capital Life Sciences Opportunities III, LP
- Kyverna Therapeutics, Inc. shareholders
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Feb 17, 2026
- Schedule 13G · Orin Hirschman · Oct 19, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Clark Ian T · May 29, 2026
- Form 4 · Cohen Fred E · May 29, 2026
- Form 4 · Seidenberg Beth C · May 29, 2026